Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422303 · ClinicalTrials.gov registry record · NA
Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02422303 is a NA study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 12 participants.
The verdict
NCT02422303, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Ketamine has been shown to have an antidepressant effect when given intravenously in doses of 2mg/kg. Ketamine is used as a standard induction drug during general anesthesia. It is known in this instance to decrease postoperative pain. No one has studied whether or not ketamine when given in doses used during general anesthesia (0.5mg/kg intravenous) has an antidepressant effect on surgical patients who suffer from depression. The study is designed to determine whether or not a small dose of ketamine when given at the induction of anesthesia could have an antidepressant effect on surgical patients with depression.
Interventions
- DRUG ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422303
The ClinicalTrials.gov registry entry for NCT02422303 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ketamine is the first listed.
NCT02422303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02422303 about?
NCT02422303 is a clinical study titled "Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms". Ketamine has been shown to have an antidepressant effect when given intravenously in doses of 2mg/kg. Ketamine is used as a standard induction drug during general anesthesia. It is known in this instance to decrease postoperative pain. No one has studied whether or not ketamine when given in doses u...
What is the current status of trial NCT02422303?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2015-12. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02422303?
The interventions under investigation include: ketamine (DRUG).
Who is sponsoring clinical trial NCT02422303?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.